CLOZAPINE + RISPERIDONE vs PLACEBO + CLOZAPINE
Global state: 2. no significant clinical improvement ‐ CGI, short term (up to 12 weeks) · patients with schizophrenia
RISPERIDONE + CLOZAPINE showed no clear difference in global state: no significant clinical improvement ‐ CGI short term compared with PLACEBO + CLOZAPINE (low certainty).
1 finding from 1 review
- RR 1.12 [0.87, 1.44]1 study · 68 participantsLow